【大行评级|里昂:重申京东健康“跑赢大市”评级 预计首季关键绩效指标表现稳健】里昂发表报告,预计京东健康今年首季关键绩效指标表现稳健,总收入同比增长15%至153亿元,主要受惠1月以来流感爆发带动的药品需求增加,以及京东平台因以旧换新优惠政策改善的用户流量。该行预计药品销售将同比增长20%,保健品和医疗器械销售或能保持10%以上增长。该行维持对公司今年15%收入增长和6.6%的净利润率预测,重申京东健康“跑赢大市”评级及目标价45港元。

金融界
May 13, 2025
里昂发表报告,预计京东健康今年首季关键绩效指标表现稳健,总收入同比增长15%至153亿元,主要受惠1月以来流感爆发带动的药品需求增加,以及京东平台因以旧换新优惠政策改善的用户流量。该行预计药品销售将同比增长20%,保健品和医疗器械销售或能保持10%以上增长。该行维持对公司今年15%收入增长和6.6%的净利润率预测,重申京东健康“跑赢大市”评级及目标价45港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10